Z-0102-2019 Class II Terminated

Recalled by OriGen Biomedical, Inc. — Austin, TX

FDA device recall Z-0102-2019 was initiated by OriGen Biomedical, Inc. on Aug 21, 2018 and is designated Class II. Reason for recall: The catheter failed the endotoxin testing. The recall status is terminated (terminated Oct 5, 2021). Affected quantity: 106.

Recall details

Product Type
Devices
Report Date
Oct 24, 2018
Initiation Date
Aug 21, 2018
Termination Date
Oct 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
106

Product description

Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO; and ECMO Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO

Reason for recall

The catheter failed the endotoxin testing.

Distribution pattern

US Nationwide in the states of NY, AR, MO, NC, GA, LA, CO, AL, MA, CA, MI, TX, OH, MD, FL, TN, SC, OR, AZ, UT, RI, SD, PA, NM, CT. Foreign (OUS): United Arab Emirates, Kingdom of Saudi Arabia, New Zealand, Thailand

Code information

UDI: 00816203022059, lot N18687-1

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0102-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0102-2019. Report a data issue: hello@regdatalab.com.